MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear
The Portal BioRRAP will cater to all those seeking regulatory approval for biological research
Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Surgical treatment of chronic pancreatitis is challenging in children and especially laparoscopic surgery has been rarely reported, worldwide
The drug will be available in 600 hospitals and 105 DTPs
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
Subscribe To Our Newsletter & Stay Updated